Field, a Nigerian healthtech company, has developed a route-to-market service aimed at introducing innovative solutions to maternal mortality, infant health and nutrition challenges.
The program, supported by an initial investment of $11 million from the Bill & Melinda Gates Foundation, will leverage Field’s proprietary technology, distribution network and financial capabilities.
The initiative currently empowers more than 40,000 healthcare providers, including private and public, in rural and urban areas in Kenya and Nigeria.
Founded in 2015 by Michael Moreland and Justin Lorenzo, Field started as a pharmaceutical supply chain provider in Nigeria and Kenya with a mission to transform the pharmaceutical value chain.
Michael Moreland, CEO and Founder of Field, believes that using digital technology to strengthen, connect, and finance health systems at scale will significantly improve access to quality care. I emphasized. He said the support from the Bill & Melinda Gates Foundation will enable the company to accelerate its efforts to improve maternal and child survival in a variety of settings.
Field services will provide pregnant women in Africa with access to new medicines, such as heat-stable carbetocin and tailored drapes, to identify and treat postpartum hemorrhage, the leading cause of maternal mortality on the continent. Become. Additionally, it will facilitate the introduction of these new treatments to complement traditional medicines and address related issues such as pre-eclampsia.
Moreland noted that while progress is being made in health care delivery, the current economic climate could hinder progress without unified systems and processes. He emphasized that the company’s mission is to address these challenges.
The company’s distribution service, Shelf Life, reportedly distributes over 3,000 high-quality products across over 50 therapeutic areas, reaching over 2,500 pharmacies and hospitals in 24 cities in Nigeria and Kenya. This includes government facilities, large hospital systems, retail chains, insurance companies, and mom-and-pop drug stores.
The platform also offers trade finance solutions for priority treatments and devices, addressing the financial constraints that often hinder investment in breakthrough medical procedures.
sauce
